Ellen Bolotin, MD, PhD
Vice President Pediatric Development
Bayer HealthCare Pharmaceuticals
Ellen Bolotin is the Vice President of Pediatric Development at Bayer, responsible for overseeing pediatric global development, including small molecules, monoclonal antibodies, ADC, and radiotherapy. Her expertise is in pediatric program development from indication selection, PIP to study protocol development, networking with pediatric oncology networks, KOLs and cooperative groups. It includes early assessment and prioritization of compounds in non-competitive environment internal and external; Harmonization of regulatory submissions to FDA and EMA; Innovative clinical and statistical study design, long term follow up, education and training.
Dr. Bolotin received her MD degree from St Petersburg Pediatric Medical School and PhD from Institute of Hematology and transfusion medicine training in Pediatric Hematology/Oncology at University of Southern California and has held academic positions at USC and City of Hope in Pediatric Hematology/Oncology and bone marrow transplantation. Prior to Bayer, she served as Senior Director, Head of Experimental Medicine at Daichi Sankyo.